Stocks and Investing
Stocks and Investing
Wed, August 16, 2023
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Ed Arce Maintained (UNCY) at Strong Buy with Decreased Target to $4.5 on, Aug 16th, 2023
Ed Arce of HC Wainwright & Co., Maintained "Unicycive Therapeutics, Inc." (UNCY) at Strong Buy with Decreased Target from $7 to $4.5 on, Aug 16th, 2023.
Ed has made no other calls on UNCY in the last 4 months.
There are 2 other peers that have a rating on UNCY. Out of the 2 peers that are also analyzing UNCY, 0 agree with Ed's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Ed
- Elemer Piros of "EF Hutton" Reiterated at Strong Buy and Held Target at $5 on, Friday, June 30th, 2023
- Bruce Jackson of "Benchmark" Reiterated at Buy and Held Target at $3 on, Tuesday, June 20th, 2023
Contributing Sources